Senior Scientist
Boehringer Ingelheim
I am a senior scientist in DMPK Bioanalytical Sciences group at Boehringer Ingelheim. My responsibility is to develop immunogenicity methods to support immunogenicity risk assessment of peptide and ADC programs. Prior to joining BI, I worked at Wuxi AppTec and Frontage Laboratories and was responsible for method development and validation of ADA/NAb, PK and biomarker assays to support nonclinical/clinical studies. Prior to that, I worked on antibody engineering at Eli Lilly.